What was studied?
The investigators studied rat tendon explants and cultured tendon fibroblasts, including cell movement, survival under oxidative stress and signaling pathways.
What did the researchers report?
BPC-157 was associated with increased explant outgrowth and cell migration, with changes in FAK-paxillin signaling. The proliferation assay did not show a direct increase in cell proliferation.
What are the limits?
This was not a human injury trial. Cell migration and explant outgrowth do not establish faster recovery, human safety or a clinical indication. The results also cannot be assumed to apply to a BPC-157 combination product.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.